Clinical Trials Logo

Clinical Trial Summary

The Direction Générale de l'Organisation des Soins (DGOS) and the Banque Nationale de Données Maladies Rares (BNDMR) have launched a call for a letter of commitment for the implementation of a diagnostic observatory in order to fight against diagnostic wandering and impasse. In this context, the AnDDI-Rares network proposes 3 work packages (WP) to respond to the missions entrusted to it. Work package 1 of the diagnostic observatory includes a retrospective and prospective study to evaluate how diagnostic wandering and impasse has evolved within the network, with regard to the integration of new technologies, and the expectations of patients and their families. Work package 2 of the diagnostic observatory includes a reassessment of sporadic copy number variations (CNV) of unknown significance of more than 1 Mb obtained since the beginning of CGH array analyses in the territory. Work package 3 of the diagnostic observatory aims to help put an end to diagnostic wandering for patients with certain emblematic syndromes by proposing genome and RNA analysis, which provides a certain diagnosis and negative targeted molecular study.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05448326
Study type Observational
Source Centre Hospitalier Universitaire Dijon
Contact Laurence OLIVIER-FAIVRE
Phone 0380295313
Email laurence.faivre@chu-dijon.fr
Status Recruiting
Phase
Start date March 28, 2022
Completion date March 2027